Published in Diabetes on July 01, 1995
Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am J Pathol (2009) 2.01
Genetic modulation of diabetic nephropathy among mouse strains with Ins2 Akita mutation. Physiol Rep (2014) 0.79
Dual therapy of rosiglitazone/pioglitazone with glimepiride on diabetic nephropathy in experimentally induced type 2 diabetes rats. J Biomed Res (2011) 0.77
The missing link: studying the alternative TGF-β pathway provides a unifying theory for different components of diabetic nephropathy. Diabetes (2015) 0.77
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med (2001) 22.32
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet (1999) 4.81
Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ (1991) 4.46
Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res (1999) 4.38
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists. Science (1988) 4.00
Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet (1983) 3.01
Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy. Diabetes Care (2000) 2.97
A new psychosocial screening instrument for use with cancer patients. Psychosomatics (2001) 2.81
Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) (1982) 2.75
Breakthrough pain: characteristics and impact in patients with cancer pain. Pain (1999) 2.53
Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J (Clin Res Ed) (1987) 2.35
Mechanisms of edema formation in myxedema--increased protein extravasation and relatively slow lymphatic drainage. N Engl J Med (1979) 2.21
Progress toward guidelines for the management of fatigue. Oncology (Williston Park) (1998) 2.12
2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science (1990) 2.01
Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ (1996) 2.00
Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney Int (2000) 1.85
Is diabetic nephropathy an inherited complication? Kidney Int (1992) 1.79
Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J (Clin Res Ed) (1986) 1.68
An (11;21) translocation in four generations with chromosome 11 abnormalities in the offspring. A clinical, cytogenetical, and gene marker study. Hum Hered (1973) 1.64
Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism (1983) 1.56
Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively. Kidney Int (2001) 1.55
A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia (1981) 1.53
Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics. Diabetologia (1981) 1.53
Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes (1995) 1.51
Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy. Diabetologia (1990) 1.49
Monitoring kidney function in diabetic nephropathy. Diabetologia (1994) 1.47
Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int (2000) 1.46
Progression of diabetic nephropathy. Kidney Int (2001) 1.46
Diabetic nephropathy and arterial hypertension. Diabetologia (1983) 1.45
Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial. Diabetologia (2008) 1.44
Prevalence of microalbuminuria in children with type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1986) 1.41
Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. Diabetologia (1994) 1.40
Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients. Diabetes Care (1998) 1.40
Ring chromosome 18 in mother and daughter. J Ment Defic Res (1970) 1.39
The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan). J Renin Angiotensin Aldosterone Syst (2000) 1.35
Partial trisomy 12 in a mentally retarded boy and translocation (12;21) in his mother. J Med Genet (1974) 1.35
Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitus. Diabet Med (2001) 1.34
Increased urinary albumin-excretion rate in benign essential hypertension. Lancet (1974) 1.28
Acute reduction of arterial blood pressure reduces urinary albumin excretion in type 1 (insulin-dependent) diabetic patients with incipient nephropathy. Diabetologia (1986) 1.26
Carrier detection and X-inactivation studies in the fragile X syndrome. Cytogenetic studies in 63 obligate and potential carriers of the fragile X. Hum Genet (1983) 1.26
Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy. Kidney Int (2006) 1.24
Short stature and diabetic nephropathy. BMJ (1995) 1.24
Effect of intravenous glucose infusion on renal function in normal man and in insulin-dependent diabetics. Diabetologia (1981) 1.24
Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1993) 1.23
Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes (1995) 1.20
The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics. Diabetologia (1976) 1.20
Chronic segmental spinal muscular atrophy of upper extremities in identical twins. Neurology (1990) 1.18
Neuropsychiatric manifestations of AIDS-spectrum disorders. Hosp Community Psychiatry (1986) 1.18
Glomerular structure and function in diabetic nephropathy. Early to advanced stages. Diabetes (1990) 1.18
ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma. Proc Natl Acad Sci U S A (1998) 1.17
Renal function in streptozotocin-diabetic rats. Diabetologia (1981) 1.13
Changes in renal function during weight loss induced by high vs low-protein low-fat diets in overweight subjects. Int J Obes Relat Metab Disord (1999) 1.10
The 48,XXYY syndrome. J Ment Defic Res (1978) 1.10
Benefits of long-term antihypertensive treatment on prognosis in diabetic nephropathy. Kidney Int (1996) 1.09
Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy. Diabet Med (2000) 1.08
Anaemia in diabetes: Is there a rationale to TREAT? Diabetologia (2006) 1.08
HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population. Tissue Antigens (1986) 1.08
QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes. Scand J Clin Lab Invest (2000) 1.08
Possible localization of Gc-System on chromosome 4. Loss of long arm 4 material associated with father-child incompatibility within the Gc-System. Hum Hered (1977) 1.08
Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy. Kidney Int Suppl (2000) 1.07
Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia (1984) 1.07
The effect of hypoxia and carbon monoxide exposure on plasma volume and capillary permeability to albumin. Scand J Clin Lab Invest (1972) 1.07
Increased serum concentration of von Willebrand factor in non-insulin dependent diabetic patients with and without diabetic nephropathy. BMJ (1995) 1.07
A strong correlation between glomerular filtration rate and filtration surface in diabetic nephropathy. Diabetologia (1988) 1.06
Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy. Diabetes Care (1996) 1.05
Kidney function and size in diabetics before and during initial insulin treatment. Kidney Int (1982) 1.05
Effects of insulin on kidney function and sodium excretion in healthy subjects. Diabetologia (1989) 1.05
A combined abnormality in heart rate variation and QT corrected interval is a strong predictor of cardiovascular death in type 1 diabetes. Scand J Clin Lab Invest (2008) 1.04
Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in Type 2 diabetic patients. Diabet Med (2001) 1.03
Early changes in diabetic retinopathy: capillary loss and blood-retina barrier permeability in relation to metabolic control. Acta Ophthalmol (Copenh) (1994) 1.03
Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes (1997) 1.03
Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes (1993) 1.02
Stable glomerular filtration rate in normotensive IDDM patients with stable microalbuminuria. A 5-year prospective study. Diabetes Care (1997) 1.02
Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients. Kidney Int (1997) 1.00
The trisomy 8 syndrome: report of two further cases. Ann Genet (1974) 1.00
Acid glycosaminoglycans in myxoedema. Clin Endocrinol (Oxf) (1982) 1.00
Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: the role of aldosterone. Horm Metab Res (2005) 1.00
Haemodynamic changes in insulin-induced hypoglycaemia in normal man. Diabetologia (1984) 0.99
Effects of indomethacin on glomerular hemodynamics in experimental diabetes. Kidney Int (1986) 0.99
The effect of intravenous insulin infusion on kidney function in insulin-dependent diabetes mellitus. Diabetologia (1981) 0.99
Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme. Diabet Med (2011) 0.98
A ring chromosome, diagnosed by quinacrine fluorescence as No. 9, in a mentally retarded girl. Clin Genet (1973) 0.98
Glomerular permselectivity in early stages of overt diabetic nephropathy. Kidney Int (2000) 0.96
Quantification of human seminiferous epithelium. II. Histological studies in eight 47,XYY men. J Reprod Fertil (1973) 0.95